Tryptamine Therapeutics is edging closer to first patient dosing in its world-first clinical trial for binge eating disorder ...

Summit Biotech Fund backs opportunities in the ASX healthcare space and sees upside in three particular names including ...

The healthcare sector rose 9.05% in July to be the best of the 11 ASX sectors. A turn up for the books to be sure. While ...

Fibromyalgia, a complex chronic pain disorder marked by widespread pain, fatigue, and cognitive issues, is witnessing evolving treatment advancements ...